Cargando…

Visualization of the individual blood microbiome to study the etiology of sarcoidosis

INTRODUCTION: Single microbial pathogens or host-microbiome dysbiosis are the causes of lung diseases with suspected infectious etiology. Metagenome sequencing provides an overview of the microbiome content. Due to the rarity of most granulomatous lung diseases collecting large systematic datasets i...

Descripción completa

Detalles Bibliográficos
Autores principales: Hodzhev, Yordan, Tsafarova, Borislava, Tolchkov, Vladimir, Youroukova, Vania, Ivanova, Silvia, Kostadinov, Dimitar, Yanev, Nikolay, Zhelyazkova, Maya, Tsonev, Stefan, Kalfin, Reni, Panaiotov, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Research Network of Computational and Structural Biotechnology 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10624578/
https://www.ncbi.nlm.nih.gov/pubmed/37928975
http://dx.doi.org/10.1016/j.csbj.2023.10.027
Descripción
Sumario:INTRODUCTION: Single microbial pathogens or host-microbiome dysbiosis are the causes of lung diseases with suspected infectious etiology. Metagenome sequencing provides an overview of the microbiome content. Due to the rarity of most granulomatous lung diseases collecting large systematic datasets is challenging. Thus, single-patient data often can only be summarized visually. OBJECTIVE: To increase the information gain from a single-case metagenome analysis we suggest a quantitative and qualitative approach. RESULTS: The 16S metagenomic results of 7 patients with pulmonary sarcoidosis were compared with those of 22 healthy individuals. From lysed blood, total microbial DNA was extracted and sequenced. Cleaned data reads were identified taxonomically using Kraken 2 software. Individual metagenomic data were visualized with a Sankey diagram, Krona chart, and a heat-map. We identified five genera that were exclusively present or significantly enhanced in patients with sarcoidosis - Veillonella, Prevotella, Cutibacterium, Corynebacterium, and Streptococcus. CONCLUSIONS: Our approach can characterize the blood microbiome composition and diversity in rare diseases at an individual level. Investigation of the blood microbiome in patients with granulomatous lung diseases of unknown etiology, such as sarcoidosis could enhance our comprehension of their origin and pathogenesis and potentially uncover novel personalized therapeutics.